Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by NewToInvesting7on May 12, 2021 12:04pm
120 Views
Post# 33183063

RE:⚡⚡⚡ SZLS should focus on Aristotle, forget covid tests

RE:⚡⚡⚡ SZLS should focus on Aristotle, forget covid testsRespectfully disagree.  

If SZLS could stop Covid testing today, and replace 100% of that lost revenues with Aristotle revenues, then maybe I can see it.  However, I do not believe they are running the lab at 100% capacity, so no need for them to forget Covid tests.  Simply continue with the Covid testing, and ramp up Aristotle testing.  Once Aristotle testing is at a level that would require use of 100% of the lab, then stop with the Covid testing, if it would not impact long term partnerships - i.e., partners that use SZLS for both Aristotle and Covid testing.

Cheers!


DobreCoffee wrote:
More info at: https://www.businesswire.com/news/home/20210112005454/en/Calgary-Biotech-Company-%E2%80%9CCardiAI%E2%80%9D-Receives-Provincial-Regulatory-Approval-for-New-Laboratory


<< Previous
Bullboard Posts
Next >>